№ lp_2_3_38600
Commissioning policy outlining funding restrictions and clinical rationale for intra-articular hyaluronic acid injections in osteoarthritis within the NHS framework, including consultation history, governance approval, and evidence references.
Policy Category: INNF
Subject: Hyalurons, Hyaluronic Acid (Durolane) or viscosupplementation
Indication: Osteoarthritis
Commissioning Status: Low priority for funding; not normally funded
Funding Process: Individual Funding Request via Gloucestershire Clinical Commissioning Group
Date of Publication: 12 October 2015
Policy Review Date: March 2025
Consultation Bodies: MSK Clinical Programme Group; GHNHSFT; GP Membership (via CCG Live/What’s New This Week)
Consultation Period: 10 July – 7 August 2015
Patient Representative Involvement: Yes (via CPG and ECCP membership)
Reviewing Bodies: Effective Clinical Commissioning Policy Group; Integrated Governance and Quality Committee
Evidence Base: NICE Clinical Guideline 177; peer-reviewed journal articles (2012)
Relevant Authority: National Institute for Health and Clinical Excellence
Health System: National Health Service
Commissioning Body Contact: Gloucestershire Clinical Commissioning Group ([email protected]
Note: )
Version History: Version 1 (12.10.15); Version 2 (15.03.18, review date amended); Version 3 (10.03.22, review date amended to March 2025, no policy changes)
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.

Don’t have cryptocurrency yet?

You can still complete your purchase in a few minutes:
  1. Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
  2. In the app, tap Send.
  3. Select network, paste our wallet address.
  4. Send the exact amount shown above.
After sending, paste your TXID (transaction ID) and your email to receive the download link. Need help? Contact support and we’ll guide you step by step.